NVS 股票新闻 — 实时报道

NVS 最新新闻

NVS 的最新新闻报道，汇总自华尔街日报、彭博、纽约时报、金融时报与 Google 新闻，实时更新，免费无广告。标题保留原文。

1. Failure of Novartis’ Pelacarsen Could Reshape the Lp(a) Race for CRISPR and IonisYahoo Finance · 2026-09-24
2. Novartis (NVS) Faces Another Pipeline Setback as ALS Drug Fails Mid-Stage TrialYahoo Finance · 2026-09-21
3. ETFs Investing in Novartis AG Sponsored ADR StocksTradingView · 2026-09-21
4. Novartis (NVS) Suffers its Third Drug Trial Setback in a Week, and its Worst Trading Day in YearsYahoo Finance · 2026-09-17
5. Why Is Novartis Stock Trading Higher Today? - Novartis (NYSE:NVS)Benzinga · 2026-09-17
6. Novartis (NVS) and Ionis (IONS)’ Big Cholesterol Bet Comes Up Short in Late-Stage TrialYahoo Finance · 2026-09-17
7. Novartis halts ALS drug post mid-stage trial setback (NVS:NYSE)Seeking Alpha · 2026-09-16
8. Novartis Just Shook Up a Multibillion-Dollar Drug Race. What It Means for Eli Lilly Stock.The Motley Fool · 2026-09-14
9. Jim Cramer Weighs Amgen (AMGN) After Novartis Trial FailureYahoo Finance · 2026-09-12
10. Novartis's $30 Billion Deal Spree Triggers a Boardroom ReckoningYahoo Finance · 2026-09-11
11. Drug Trial Setbacks Raise Questions Over Novartis (NVS)’s Growth PipelineYahoo Finance · 2026-09-11
12. Novartis investors turn spotlight on M&A after trial setbacksYahoo Finance · 2026-09-11
13. Top Investor Urges Novartis for Stronger Acquisition Oversight After M&A and Trial SetbacksYahoo Finance · 2026-09-11
14. Novartis Rebounds as $30 Billion Wipeout Draws Board ChallengeTradingView · 2026-09-10
15. HSBC upgrades Novartis stock rating to hold on pipeline clarityInvesting.com · 2026-09-10

NVS 期权：最大痛点、Gamma 敞口（GEX）与关键价位 · 在新闻存档中搜索 NVS · 全部股票